The Impact of Addition of Consolidation Chemotherapy to Standard Cisplatin-Based Chemoradiotherapy in Uterine Cervical Cancer: Matter of Distant Relapse

BACKGROUND: Treatment of advanced uterine cervical cancer has advanced little in the last 15 years. Although two phase III trials showed survival benefit with the addition of consolidation chemotherapy (CT) after cisplatin-based chemoradiotherapy (RTCT), it is not considered standard of care. We aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabri, Vanessa A., Queiroz, Ana C. M., Mantoan, Henrique, Sanches, Solange M., Guimarães, Andrea P. G., Ribeiro, Adriana R. G., Souza, Ronaldo P., Maya, Joyce M. L., Santos, Elizabeth S., Castro, Fabrício S., Lima, João P. N. S., Chen, Michael J., Baiocchi, Glauco, da Costa, Alexandre A. B. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432701/
https://www.ncbi.nlm.nih.gov/pubmed/30984261
http://dx.doi.org/10.1155/2019/1217838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432701/
https://www.ncbi.nlm.nih.gov/pubmed/30984261
http://dx.doi.org/10.1155/2019/1217838

Ejemplares similares